These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3923777

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal).
    Callaghan N, O'Hare J, O'Driscoll D, O'Neill B, Daly M.
    Dev Med Child Neurol; 1982 Dec; 24(6):830-6. PubMed ID: 6818076
    [No Abstract] [Full Text] [Related]

  • 4. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB, Mohamed K, Marson AG.
    Cochrane Database Syst Rev; 2003 Dec; (3):CD003032. PubMed ID: 12917940
    [Abstract] [Full Text] [Related]

  • 5. Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy?
    Schmitt B, Kovacevic-Preradovic T, Critelli H, Molinari L.
    Neuropediatrics; 2007 Apr; 38(2):83-7. PubMed ID: 17712736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Absence seizures: valproate or ethosuximide?
    Santavuori P.
    Acta Neurol Scand Suppl; 1983 Apr; 97():41-8. PubMed ID: 6424396
    [Abstract] [Full Text] [Related]

  • 8. Longterm follow-up of childhood epilepsy with absences. I. Epilepsy with absences at onset.
    Dieterich E, Baier WK, Doose H, Tuxhorn I, Fichsel H.
    Neuropediatrics; 1985 Aug; 16(3):149-54. PubMed ID: 3930988
    [Abstract] [Full Text] [Related]

  • 9. Ethosuximide in the treatment of absence (peptit mal) seizures.
    Browne TR, Dreifuss FE, Dyken PR, Goode DJ, Penry JK, Porter RJ, White BG, White PT.
    Neurology; 1975 Jun; 25(6):515-24. PubMed ID: 805382
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine.
    Posner EB, Mohamed K, Marson AG.
    Seizure; 2005 Mar; 14(2):117-22. PubMed ID: 15694565
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of lamotrigine in the treatment of absence epilepsy crises].
    Mauri-Llerda JA, Tejero-Juste C, Iñiguez C, Morales-Asín F.
    Rev Neurol; 2005 Mar; 32(3):247-50. PubMed ID: 11310280
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative profiles of sodium valproate and ethosuximide on electro-behavioural correlates in gamma-hydroxybutyrate and pentylenetetrazol induced absence seizures in rats.
    Kumaresan S, David J, Joseph T.
    Indian J Physiol Pharmacol; 2000 Oct; 44(4):411-8. PubMed ID: 11214495
    [Abstract] [Full Text] [Related]

  • 16. Spectral analysis of the EEG in children during the introduction of antiepileptic therapy with valproic acid.
    Benninger C, Matthis P, Scheffner D.
    Neuropsychobiology; 1985 Oct; 13(1-2):93-6. PubMed ID: 3929157
    [Abstract] [Full Text] [Related]

  • 17. Valproate-ethosuximide combination therapy for refractory absence seizures.
    Rowan AJ, Meijer JW, de Beer-Pawlikowski N, van der Geest P, Meinardi H.
    Arch Neurol; 1983 Dec; 40(13):797-802. PubMed ID: 6416232
    [Abstract] [Full Text] [Related]

  • 18. Valproic acid (Depakene). A new anticonvulsant agent.
    Lewis JR.
    JAMA; 1978 Nov 10; 240(20):2190-2. PubMed ID: 100622
    [Abstract] [Full Text] [Related]

  • 19. Development of tolerance to the anticonvulsant effect of valproate but not to ethosuximide in a rat model of absence epilepsy.
    Wahle H, Frey HH.
    Eur J Pharmacol; 1990 May 31; 181(1-2):1-8. PubMed ID: 2117539
    [Abstract] [Full Text] [Related]

  • 20. Huperzine A suppresses absence seizures in the genetic absence epilepsy rat from Strasbourg (GAERS) model of genetic generalized epilepsy with absence seizures.
    Casillas-Espinosa PM, Garcia-Olivares J, Li R, Li C, Yu C, Formella AE, O'Brien TJ.
    Epilepsia Open; 2024 Oct 31; 9(5):1826-1836. PubMed ID: 39096485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.